Southern States AACE 2019 Annual Meeting - February 15-17, 2019

Birmingham, AL US
February 15, 2019 to February 17, 2019

The Southern States Chapter of AACE Annual Meeting is designed to provide a forum devoted exclusively to endocrinology at which leaders in the field present recent clinical updates and other relevant clinical information. 


Target Audience

Endocrinologists, MD/DOs, advance practice clinicians, and other interested healthcare professionals who are interested in the treatment of endocrine disease states that reside or practice in Alabama, Louisiana, Mississippi, and Tennessee. 

Learning Objectives

At the end of this activity, participants will be able to: 

  • Discuss the latest scientific and clinical discoveries in the field of endocrinology and diabetes.  
  • Apply new found knowledge to the diagnosis and management of patients with disorders of endocrinology, diabetes or metabolism for improved patient outcomes. 
  • Establish new collaborations and relationships with peers for improved personal and professional support. 
Additional information
Available for MOC Points?: 
Practice Area: 
General Endo
Course summary
Available credit: 
  • 12.00 AMA
  • 12.00 Attendance
Course opens: 
Course expires: 
Event starts: 
02/15/2019 - 3:45pm
Event ends: 
02/17/2019 - 11:30am

Friday, February 15, 2019

3:15 – 3:45 PM                  Registration


3:45 – 4:00 PM                  Opening Remarks & Pre-Meeting Assessment

4:00 – 5:00 PM                  Diabetes Technology: Pumps, Sensors and Closed Loop Systems

                                                Bruce Bode, MD, FACE                                             

5:00 – 6:00 PM                  Diabetes Case Studies

                                                Bruce Bode, MD, FACE                                               

6:00 – 6:15 PM                  Post-Meeting Assessment

6:15 – 7:15 PM                  Welcome Reception / Exhibits


Saturday, February 16, 2019

7:00 – 7:30 AM              Continental Breakfast / Registration Open

7:30 – 7:45 AM              Pre-Meeting Assessment

7:45 – 8:45 AM              Current Lipid Management: The AACE Guidelines, a case-based approach

                                        Paul Jellinger, MD, MACE                                      

8:45 – 9:45 AM              Diabetes Cardiovascular Outcomes Trials

                                       Vivian Fonseca, MD, FACE

10:00 – 11:00 AM          Break / Exhibits

11:00 – 12:00 PM          Acromegaly Update

                                        Brooks Vaughan, MD

12:00 – 1:30 PM            Lunch

12:15 – 1:15 PM            Exercise as Medicine

                                       Eric P. Plaisance, PhD, FACSM

1:30 – 2:30 PM              Molecular Markers & Evaluation of Thyroid Nodules/Neoplasia

                                           Stephanie Lee, MD, PhD, FACE, ECNU

2:30 – 3:30 PM              Treating Obesity & Related Metabolic Diseases: Is stomach surgery the solution?

                                        Virginia Weaver, MD

3:30 – 4:30 PM              Endocrine Toxicities of Oncoimmunotherapy

                                        David Portnoy, MD, FACP

4:30 PM                          Adjourn

7:00 PM                          Family Dinner at The Fish Market


Sunday, February 17. 2019

7:30 – 8:00 AM              Coffee Break

8:00 – 9:00 AM              Hypophosphatasia & Unusual Bone Disorders

                                        Kathryn Dahir, MD               

9:00 – 10:00 AM            "Doc, Why Am I So Tired and Sleepy?"

                                         Patricia Patterson, MD

10:00 – 10:15 AM          Post Assessment

10:15 – 11:30 AM          Family Brunch / Chapter Business Meeting  

11:30 AM                       Adjourn

Sheraton Birmingham Hotel
2101 Richard Arrington Jr Blvd N
Birmingham, AL 35203
United States
  • Bruce Bode, MD, FACE
  • Paul Jellinger, MD, MACE
  • Vivian Fonseca, MD, FACE
  • Brooks Vaughan, MD
  • Eric P. Plaisance, PhD, FACSM
  • Sephanie Lee, MD, PhD, FACE, ECNU
  • Virginia Weaver, MD
  • David Portnoy, MD, FACP
  • Kathryn Dahir, MD
  • Patricia Patterson, MD



Faculty Disclosures



Commercial Interest


Bruce Bode, MD, FACE

1. Abbott

2. Becton Dickinson

3. Dexcom

4. Eli Lilly


5. Medtronic


6. Novo Nordisk


7. Senseonics


1. Research Grant

2. Research Grant

3. Research Grant

4. Consulting Fees, Research Grant

5. Honorarium, Consulting Fees, Research Grant

6. Honorarium, Consulting Fees, Research Grant

7. Consulting Fees, Research Grant

Kathryn Dahir, MD

1. Regeneron

2. Alexion

3. Ultragenyx


1. Research Grant

2. Research Grant

3. Research Grant

Vivian Fonseca, MD, FACE


1. Asahi

2. Bayer

3. Boehringer Ingelheim


1. Consulting Fees, Research Grant

2. Grant/Research Support

3. Research Suport

Paul Jellinger, MD, MACE

1. Amgen

2. Regeneron

3. Merck

1. Honorarium, Consulting Fees

2. Honorarium, Consulting Fees

3. Honorarium, Consulting Fees


Lisa Usdan, MD, FACE

1. Merck

1. Stockholder


Brooks Vaughan, MD

1. Ionis Pharmaceuticals

1. Research Grant


Virginia Weaver, MD

1. Ethicon Endo-Surgery

2. Gore

1. Consulting Fees

2. Consulting Fees


All other faculty, planners and staff have disclosed no relevant financial relationships with commercial interests. 



The information provided at this accredited activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. 


Declaration of Disclosure and Conflicts of Interest  

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities. 


Accreditation and Designation Statements 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Southern States Chapter of the American Association of Clinical Endocrinologists. AACE is accredited by the ACCME to provide continuing medical education for physicians. 


The American Association of Clinical Endocrinologists designates this live activity for a maximum of 12 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Available Credit

  • 12.00 AMA
  • 12.00 Attendance

Accreditation Period

Course opens: 
Course expires: 
Please login or register to take this course.